Patents by Inventor Natasha Bolick
Natasha Bolick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230277803Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.Type: ApplicationFiled: May 11, 2023Publication date: September 7, 2023Applicant: BECTON, DICKINSON AND COMPANYInventors: Joshua HORVATH, Victor POLITIS, Stephen RICHARDS, Ronald PETTIS, Gary SEARLE, Monica RIXMAN SWINNEY, Natasha BOLICK
-
Patent number: 11690973Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.Type: GrantFiled: January 4, 2013Date of Patent: July 4, 2023Assignee: Becton, Dickinson and CompanyInventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
-
Patent number: 11458281Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.Type: GrantFiled: March 31, 2017Date of Patent: October 4, 2022Assignee: BECTON, DICKINSON AND COMPANYInventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
-
Patent number: 9775947Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.Type: GrantFiled: October 18, 2016Date of Patent: October 3, 2017Assignee: Becton, Dickinson and CompanyInventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
-
Publication number: 20170203033Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.Type: ApplicationFiled: March 31, 2017Publication date: July 20, 2017Applicant: Becton, Dickinson and CompanyInventors: Joshua HORVATH, Victor POLITIS, Stephen RICHARDS, Ronald PETTIS, Gary SEARLE, Monica RIXMAN SWINNEY, Natasha BOLICK
-
Publication number: 20170035965Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.Type: ApplicationFiled: October 18, 2016Publication date: February 9, 2017Applicant: Becton, Dickinson and CompanyInventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
-
Patent number: 9480794Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.Type: GrantFiled: October 9, 2013Date of Patent: November 1, 2016Assignee: Becton, Dickinson and CompanyInventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
-
Publication number: 20150051583Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.Type: ApplicationFiled: January 4, 2013Publication date: February 19, 2015Inventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
-
Publication number: 20140107613Abstract: A medical fluid communication system is disclosed comprising a pump controller and a fluid detector. The fluid detector detects characteristics of the fluid and provides fluid measurements to the pump controller, which detects if the fluid is flowing in the medication delivery system. In the event fluid is not flowing due to an occlusion, the pump controller may attempt to resolve the occlusion or may provide a warning to a user that an occlusion is occurring.Type: ApplicationFiled: October 9, 2013Publication date: April 17, 2014Inventors: Steven Keith, Elaine McVey, Frances Tong, Ronald J. Pettis, Joshua Herr, Richard J. Klug, Christopher Rini, Natasha Bolick, Alfred Joseph Harvey, Vincent J. Sullivan, Matthew S. Ferriter
-
Publication number: 20100298672Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from a sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stimulate toxin release based on tType: ApplicationFiled: June 25, 2010Publication date: November 25, 2010Inventors: Robert D. Black, Natasha Bolick
-
Patent number: 7778695Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stiType: GrantFiled: February 19, 2009Date of Patent: August 17, 2010Assignee: Sicel Technologies, Inc.Inventors: Robert D. Black, Natasha Bolick
-
Publication number: 20090180962Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stiType: ApplicationFiled: February 19, 2009Publication date: July 16, 2009Inventors: Robert D. Black, Natasha Bolick
-
Patent number: 7510699Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stiType: GrantFiled: February 17, 2004Date of Patent: March 31, 2009Assignee: Sicel Technologies, Inc.Inventors: Robert D. Black, Natasha Bolick
-
Publication number: 20040197267Abstract: Methods, systems, devices and computer program product include: (i) administering a fluorescent analyte to a subject; (ii) repetitively emitting excitation light from an implanted sensor over a desired monitoring period; (iii) detecting fluorescence intensity in response to the excitation light using the implanted sensor that outputs the excitation light; and (iv) using data associated with the detected fluorescence intensity to perform at least one of: (a) calculate the concentration or dose of the analyte received proximate to the implanted sensor site; (b) evaluate the pharmacodynamic or pharmacokinetic activity of the fluorescent analyte; (c) confirm Ab attachment to a tumor site; (d) monitor a non-target site to confirm it is not unduly affected by a therapy; (e) monitor for changes in cellular properties; (f) use the calculated dose or concentration data to adjust or customize a therapeutic amount of the analyte administered to the subject; (g) confirm micelle concentration at a target site and then stiType: ApplicationFiled: February 17, 2004Publication date: October 7, 2004Inventors: Robert D. Black, Natasha Bolick